MOBERG PHARMA AB PUBL Stock Price, News & Analysis
Company Description
MOBERG PHARMA AB PUBL (OTC Link: MBGPF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $45.4M.
MBGPF stock has gained 40.9% over the past year. Shares last traded at $1.00.
This page provides a comprehensive overview of MBGPF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
MOBERG PHARMA AB PUBL (MBGPF) stock last traded at $1.00. Over the past 12 months, the stock has gained 40.9%. At a market capitalization of $45.4M, MBGPF is classified as a micro-cap stock with approximately 47.0M shares outstanding.
Latest News
MOBERG PHARMA AB PUBL has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial. View all MBGPF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in MOBERG PHARMA AB PUBL (MBGPF) currently stands at 6.0 thousand shares, up 1000.0% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 76.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for MOBERG PHARMA AB PUBL (MBGPF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
MBGPF Company Profile & Sector Positioning
MOBERG PHARMA AB PUBL (MBGPF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing MBGPF often look at related companies in the same sector, including Eagle Pharmaceut (EGRX), Healthy Extracts Inc (HYEX), Leef Brands (LEEEF), C21 Investments (CXXIF), and Rubicon Organics (ROMJF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate MBGPF's relative position within its industry.